PP_1170x120_10-25-21

Novel Laboratories

Lupin to acquire Gavis Pharmaceuticals

Lupin to acquire Gavis Pharmaceuticals

MUMBAI, India — Lupin Ltd. plans to buy Gavis Pharmaceuticals LLC and Novel Laboratories Inc. in an $880 million deal. Lupin said Thursday that the acquisition will boost its scale in the U.S. generic drug market and broadens its pipeline in dermatology, controlled-substance products, and other high-value and niche generics. In addition, Gavis brings a